GSK and Spero Therapeutics' oral cabapenem, tebipenem HBr, has become the first antibiotic in the class to show efficacy in a ...

Dangerous infections that no longer respond to antibiotics are spreading quickly around the world, increasing by as much as 15% a year.

A young boy in Nebraska may well have been saved thanks to a particular piece of rotten eggplant collected in South Africa.

Zoliflodacin, an investigational single-dose oral antibiotic for uncomplicated gonorrhea, to be featured in oral presentation ...

Have you ever returned from a grocery run, unloaded your bags and questioned some of your choices? It's time for a new, more strategic approach to your shopping ...

Common infections are becoming more resistant to treatment, and it's leaving experts worried for vulnerable groups.

USAntibiotics, the country’s only domestic manufacturer of amoxicillin (Amoxil®) and amoxicillin clavulanate (Augmentin®), ...

The recalled products were not provided to schools through the USDA National School Lunch Program, but may have been sold to ...

NanoViricides, Inc. (NYSE American: NNVC ) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced that it will be ...

Innoviva Specialty Therapeutics, a subsidiary of Innoviva, Inc., recently presented new clinical data on zoliflodacin at the Infectious Disease Society of America’s IDWeek 2025 in Atlanta, Georgia, ...

Lead antibacterial compound against a novel target in Gram-negative bacteria validated in infection models; Progressing a platform of small-molecule enzymatic activators that indu ...